Background illustration for clinical trials search

Paid Clinical Trials Fairfield

Discover 2,551 paid clinical trials in Fairfield, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 2,551

Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer

for

Metastatic Nasopharyngeal Carcinoma,

Location: Vallejo CA, Walnut Creek CA, San Rafael CA, Oakland CA,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06029270

Phase 2, Recruiting

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

for

Muscle Invasive Bladder Urothelial Carcinoma,

Location: Vallejo CA, Walnut Creek CA, San Rafael CA, Oakland CA,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05987241

Phase 2, Phase 3, Recruiting

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

for

Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8

Location: Vallejo CA, Walnut Creek CA, San Rafael CA, Woodland CA,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 5 - 60

Code: NCT05675410

Phase 3, Recruiting

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

for

Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors

Location: Vallejo CA, Walnut Creek CA, Berkeley CA, Oakland CA,

Sponsor: American Society of Clinical Oncology

Sex: All

Age: 12+

Code: NCT02693535

Phase 2, Recruiting

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

for

Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum

Location: Vallejo CA, Martinez CA, Woodland CA, Elk Grove CA,

Sponsor: NRG Oncology

Sex: All

Age: 45 - 70

Code: NCT05080673

Recruiting

Safety and PK of Intrathecal CNTX-3001 for Intractable Chronic Low Back Pain

for

Lower Back Pain

Location: Napa CA

Sponsor: Centrexion Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07122453

Phase 1, Recruiting

Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)

for

Complex Regional Pain Syndrome Type I

Location: Napa CA, Reno NV, Santa Monica CA, Pasadena CA,

Sponsor: Ambros Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07210515

Phase 3, Recruiting

Clinical Trial Evaluating the Safety and Efficacy of Nucleus Pulposus Allograft in Participants With Degenerative Disc Disease

for

Degenerative Disc Disease, Disc Degeneration,

Location: Napa CA, Reno NV, Santa Monica CA, Eugene OR,

Sponsor: VIVEX Biologics, Inc.

Sex: All

Age: 22 - 70+

Code: NCT06778447

Recruiting

Family Communications After Genetic Testing

for

Colon Adenocarcinoma, Colorectal Adenocarcinoma,

Location: Napa CA, St. Helena CA, Woodland CA, Elk Grove CA,

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT07143487

Recruiting

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

for

Anaplastic Large Cell Lymphoma, ALK-Negative,

Location: Napa CA, Santa Rosa CA, Burbank CA, Duarte CA,

Sponsor: Eastern Cooperative Oncology Group

Sex: All

Age: 18 - 70+

Code: NCT06724237

Phase 3, Recruiting

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

for

Prostate Cancer (Adenocarcinoma)

Location: Napa CA, Emeryville CA, Woodland CA, Elk Grove CA,

Sponsor: Canadian Cancer Trials Group

Sex: Male

Age: 18+

Code: NCT06592924

Phase 3, Recruiting

Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction

for

Central Line Associated Blood Stream Infections (CLABSI)

Location: Napa CA, Santa Rosa CA, Mission Hills CA, Tarzana CA,

Sponsor: Swedish Medical Center

Sex: All

Age: 18+

Code: NCT07108660

Recruiting

Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

for

Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8,

Location: Napa CA, Woodland CA, Elk Grove CA, Santa Rosa CA,

Sponsor: SWOG Cancer Research Network

Sex: Male

Age: 18+

Code: NCT05806515

Phase 2, Recruiting

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

for

Acral Lentiginous Melanoma,

Location: Napa CA, Martinez CA, Walnut Creek CA, Emeryville CA,

Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT04511013

Phase 2, Recruiting

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

for

Childhood Extracranial Germ Cell Tumor,

Location: Napa CA, Oakland CA, Sacramento CA, Santa Rosa CA,

Sponsor: Children's Oncology Group

Sex: All

Age: 0+

Code: NCT03067181

Phase 3, Recruiting

Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers

for

Metastatic Small Intestinal Adenocarcinoma,

Location: Napa CA, Santa Rosa CA, Carson City NV, Reno NV,

Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT04205968

Phase 2, Recruiting

Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer

for

Refractory Differentiated Thyroid Gland Carcinoma

Location: Napa CA, Santa Rosa CA, Palo Alto CA, Burbank CA,

Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 18+

Code: NCT06475989

Phase 3, Recruiting

Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

for

Metastatic Malignant Neoplasm in the Liver,

Location: Napa CA, Woodland CA, Elk Grove CA, Santa Rosa CA,

Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05040360

Phase 2, Recruiting

Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma

for

Pleural Biphasic Mesothelioma, Pleural Sarcomatoid Mesothelioma

Location: Napa CA, Santa Rosa CA, Carson City NV, Reno NV,

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT05647265

Phase 2, Recruiting

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

for

Anatomic Stage II Breast Cancer AJCC v8,

Location: Vallejo CA, Berkeley CA, Sacramento CA,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06058377

Phase 3, Recruiting

Paid Clinical Trials Fairfield

Filter results

Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

Interested in new trials?

Safety and PK of Intrathecal CNTX-3001 for Intractable Chronic Low Back Pain

Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)

Clinical Trial Evaluating the Safety and Efficacy of Nucleus Pulposus Allograft in Participants With Degenerative Disc Disease

Family Communications After Genetic Testing

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction

Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers

Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer

Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer